Concepts (176)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Cytochrome P-450 CYP4A | 2 | 2018 | 4 | 0.96 | Why? |
| Arthritis, Gouty | 2 | 2018 | 22 | 0.95 | Why? |
| Arachidonate 5-Lipoxygenase | 2 | 2018 | 51 | 0.92 | Why? |
| Cyclooxygenase 2 | 2 | 2018 | 129 | 0.89 | Why? |
| Arachidonic Acid | 1 | 2018 | 90 | 0.73 | Why? |
| Phenols | 1 | 2018 | 226 | 0.64 | Why? |
| Angiotensin II | 1 | 2020 | 601 | 0.54 | Why? |
| Glucosides | 1 | 2018 | 359 | 0.54 | Why? |
| Shock, Septic | 2 | 2018 | 1313 | 0.45 | Why? |
| Macrophages | 3 | 2018 | 2784 | 0.41 | Why? |
| Hydrocortisone | 1 | 2018 | 1790 | 0.35 | Why? |
| Uric Acid | 2 | 2018 | 285 | 0.29 | Why? |
| Cardiac Surgical Procedures | 1 | 2018 | 1931 | 0.28 | Why? |
| Rats, Wistar | 3 | 2018 | 621 | 0.23 | Why? |
| Randomized Controlled Trials as Topic | 2 | 2018 | 10649 | 0.23 | Why? |
| Liver, Artificial | 1 | 2021 | 48 | 0.22 | Why? |
| RAW 264.7 Cells | 2 | 2018 | 316 | 0.22 | Why? |
| Menstruation | 1 | 2021 | 81 | 0.21 | Why? |
| Mannose-Binding Lectins | 1 | 2019 | 27 | 0.20 | Why? |
| Postoperative Complications | 1 | 2018 | 5861 | 0.19 | Why? |
| Plants, Genetically Modified | 1 | 2019 | 84 | 0.19 | Why? |
| Chondrocytes | 1 | 2018 | 35 | 0.19 | Why? |
| Mesenchymal Stem Cell Transplantation | 2 | 2021 | 1322 | 0.19 | Why? |
| Prostaglandin-E Synthases | 1 | 2018 | 21 | 0.19 | Why? |
| Arabidopsis | 1 | 2019 | 88 | 0.19 | Why? |
| Cell Polarity | 1 | 2018 | 85 | 0.18 | Why? |
| Phosphodiesterase 3 Inhibitors | 1 | 2018 | 25 | 0.18 | Why? |
| Synovial Fluid | 1 | 2018 | 64 | 0.18 | Why? |
| Sulfasalazine | 1 | 2018 | 87 | 0.18 | Why? |
| Cytochrome P-450 Enzyme Inhibitors | 1 | 2017 | 22 | 0.18 | Why? |
| Gallic Acid | 1 | 2018 | 49 | 0.18 | Why? |
| Crystallization | 1 | 2018 | 331 | 0.17 | Why? |
| Cell Movement | 2 | 2018 | 695 | 0.17 | Why? |
| Transplantation, Heterologous | 1 | 2017 | 77 | 0.17 | Why? |
| Blood Pressure Determination | 1 | 2021 | 450 | 0.17 | Why? |
| Endogenous Retroviruses | 1 | 2017 | 72 | 0.17 | Why? |
| Retroviridae Infections | 1 | 2017 | 45 | 0.17 | Why? |
| Phenotype | 2 | 2018 | 4037 | 0.16 | Why? |
| Chalcones | 1 | 2017 | 83 | 0.16 | Why? |
| STAT1 Transcription Factor | 1 | 2018 | 313 | 0.16 | Why? |
| Sus scrofa | 1 | 2017 | 205 | 0.16 | Why? |
| Endothelial Progenitor Cells | 1 | 2017 | 103 | 0.15 | Why? |
| Demyelinating Diseases | 1 | 2018 | 224 | 0.15 | Why? |
| Populus | 2 | 2019 | 4 | 0.15 | Why? |
| Microglia | 1 | 2018 | 357 | 0.14 | Why? |
| Rabbits | 1 | 2018 | 1171 | 0.14 | Why? |
| Glioma | 1 | 2017 | 189 | 0.14 | Why? |
| Plasma Exchange | 1 | 2021 | 763 | 0.13 | Why? |
| Gene Editing | 1 | 2017 | 330 | 0.13 | Why? |
| Neovascularization, Pathologic | 1 | 2017 | 305 | 0.13 | Why? |
| RNA, Long Noncoding | 1 | 2018 | 408 | 0.13 | Why? |
| Plant Leaves | 2 | 2019 | 233 | 0.13 | Why? |
| Angiogenesis Inhibitors | 1 | 2017 | 395 | 0.13 | Why? |
| Interleukin-1beta | 1 | 2018 | 992 | 0.13 | Why? |
| Sodium Chloride | 2 | 2019 | 203 | 0.12 | Why? |
| Flavonoids | 1 | 2017 | 492 | 0.12 | Why? |
| ABO Blood-Group System | 1 | 2021 | 995 | 0.12 | Why? |
| Down-Regulation | 1 | 2018 | 1416 | 0.12 | Why? |
| NF-kappa B | 1 | 2018 | 1301 | 0.11 | Why? |
| Multiple Organ Failure | 1 | 2021 | 1724 | 0.10 | Why? |
| Brain Neoplasms | 1 | 2017 | 669 | 0.10 | Why? |
| Survival Rate | 3 | 2021 | 9206 | 0.10 | Why? |
| Smartphone | 1 | 2021 | 1840 | 0.10 | Why? |
| Xylem | 1 | 2008 | 2 | 0.10 | Why? |
| Hypertension | 2 | 2021 | 8895 | 0.10 | Why? |
| Cause of Death | 2 | 2020 | 4823 | 0.10 | Why? |
| Ventricular Dysfunction, Left | 1 | 2017 | 993 | 0.09 | Why? |
| Heart Ventricles | 1 | 2017 | 1139 | 0.09 | Why? |
| Tumor Necrosis Factor-alpha | 1 | 2018 | 2483 | 0.09 | Why? |
| CRISPR-Cas Systems | 1 | 2017 | 1397 | 0.09 | Why? |
| Reactive Oxygen Species | 2 | 2019 | 1136 | 0.09 | Why? |
| MicroRNAs | 1 | 2018 | 1787 | 0.07 | Why? |
| Mice | 3 | 2018 | 21357 | 0.07 | Why? |
| Plant Roots | 2 | 2019 | 108 | 0.07 | Why? |
| Dose-Response Relationship, Drug | 3 | 2018 | 3776 | 0.07 | Why? |
| Myocarditis | 1 | 2020 | 2731 | 0.07 | Why? |
| Myocardial Infarction | 1 | 2020 | 3361 | 0.07 | Why? |
| Prognosis | 3 | 2021 | 32490 | 0.06 | Why? |
| Neutrophils | 1 | 2018 | 5476 | 0.06 | Why? |
| Signal Transduction | 1 | 2018 | 7207 | 0.06 | Why? |
| Models, Biological | 1 | 2018 | 4907 | 0.05 | Why? |
| Heart Diseases | 1 | 2018 | 3503 | 0.05 | Why? |
| Male | 12 | 2021 | 367725 | 0.05 | Why? |
| Homeostasis | 2 | 2019 | 582 | 0.05 | Why? |
| Disease Models, Animal | 1 | 2018 | 10998 | 0.05 | Why? |
| Length of Stay | 1 | 2018 | 11042 | 0.05 | Why? |
| Blood Cells | 1 | 2020 | 104 | 0.05 | Why? |
| Humans | 17 | 2021 | 930598 | 0.05 | Why? |
| Pneumonia, Viral | 4 | 2020 | 243684 | 0.05 | Why? |
| Monitoring, Immunologic | 1 | 2020 | 153 | 0.05 | Why? |
| Critical Illness | 2 | 2021 | 17281 | 0.05 | Why? |
| Coronavirus Infections | 4 | 2020 | 253789 | 0.05 | Why? |
| Cuprizone | 1 | 2018 | 7 | 0.05 | Why? |
| Retrospective Studies | 5 | 2021 | 105322 | 0.05 | Why? |
| Gene Expression Regulation, Plant | 1 | 2019 | 110 | 0.05 | Why? |
| Preliminary Data | 1 | 2020 | 457 | 0.05 | Why? |
| Animals | 5 | 2018 | 78931 | 0.05 | Why? |
| Cyclooxygenase 2 Inhibitors | 1 | 2018 | 48 | 0.05 | Why? |
| Hydroxyeicosatetraenoic Acids | 1 | 2017 | 5 | 0.04 | Why? |
| Aged | 8 | 2021 | 215776 | 0.04 | Why? |
| Chelating Agents | 1 | 2018 | 61 | 0.04 | Why? |
| Echocardiography, Doppler | 1 | 2020 | 269 | 0.04 | Why? |
| Plant Lectins | 1 | 2019 | 114 | 0.04 | Why? |
| Culture Media, Conditioned | 1 | 2017 | 66 | 0.04 | Why? |
| Cytoplasm | 1 | 2019 | 304 | 0.04 | Why? |
| Allografts | 1 | 2021 | 761 | 0.04 | Why? |
| Paracrine Communication | 1 | 2017 | 73 | 0.04 | Why? |
| Mice, Inbred C57BL | 2 | 2018 | 5542 | 0.04 | Why? |
| Xenograft Model Antitumor Assays | 1 | 2017 | 274 | 0.04 | Why? |
| Pericytes | 1 | 2017 | 108 | 0.04 | Why? |
| Critical Care | 1 | 2020 | 14081 | 0.04 | Why? |
| Mice, Nude | 1 | 2017 | 340 | 0.04 | Why? |
| Incidence | 1 | 2018 | 25622 | 0.04 | Why? |
| China | 5 | 2021 | 50654 | 0.04 | Why? |
| Tumor Burden | 1 | 2017 | 369 | 0.04 | Why? |
| Disease-Free Survival | 1 | 2021 | 1654 | 0.04 | Why? |
| Tumor Microenvironment | 1 | 2017 | 264 | 0.04 | Why? |
| Oximetry | 1 | 2020 | 658 | 0.04 | Why? |
| Female | 9 | 2021 | 380317 | 0.04 | Why? |
| Blood Coagulation Tests | 1 | 2020 | 855 | 0.04 | Why? |
| Transforming Growth Factor beta | 1 | 2017 | 363 | 0.04 | Why? |
| Global Health | 1 | 2018 | 13911 | 0.03 | Why? |
| Disease Transmission, Infectious | 1 | 2017 | 9044 | 0.03 | Why? |
| Protein Structure, Secondary | 1 | 2018 | 1077 | 0.03 | Why? |
| Treatment Outcome | 4 | 2021 | 51732 | 0.03 | Why? |
| Drug Resistance, Neoplasm | 1 | 2017 | 447 | 0.03 | Why? |
| Vascular Endothelial Growth Factor A | 1 | 2017 | 604 | 0.03 | Why? |
| Self Care | 1 | 2021 | 918 | 0.03 | Why? |
| Cell Survival | 1 | 2018 | 1581 | 0.03 | Why? |
| Neoplasms | 1 | 2021 | 17251 | 0.03 | Why? |
| Severity of Illness Index | 4 | 2021 | 48226 | 0.03 | Why? |
| Comorbidity | 3 | 2021 | 34796 | 0.03 | Why? |
| Adult | 5 | 2021 | 244371 | 0.03 | Why? |
| Combined Modality Therapy | 1 | 2020 | 3395 | 0.03 | Why? |
| Pandemics | 5 | 2021 | 389249 | 0.03 | Why? |
| Rats | 1 | 2018 | 2764 | 0.03 | Why? |
| Coronary Angiography | 1 | 2020 | 2275 | 0.03 | Why? |
| Health Services for the Aged | 1 | 2017 | 602 | 0.02 | Why? |
| Cell Proliferation | 1 | 2017 | 1973 | 0.02 | Why? |
| Electron Probe Microanalysis | 1 | 2008 | 2 | 0.02 | Why? |
| Wood | 1 | 2008 | 29 | 0.02 | Why? |
| Hospitalization | 1 | 2020 | 54280 | 0.02 | Why? |
| Antihypertensive Agents | 1 | 2021 | 1962 | 0.02 | Why? |
| Ions | 1 | 2008 | 73 | 0.02 | Why? |
| Cell Line, Tumor | 1 | 2017 | 3608 | 0.02 | Why? |
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 1454 | 0.02 | Why? |
| Middle Aged | 6 | 2021 | 270681 | 0.02 | Why? |
| Disease Susceptibility | 1 | 2021 | 4002 | 0.02 | Why? |
| Hospitals, University | 1 | 2020 | 4173 | 0.02 | Why? |
| Biomarkers | 2 | 2021 | 23361 | 0.02 | Why? |
| Cells, Cultured | 1 | 2018 | 5835 | 0.02 | Why? |
| Mice, Inbred BALB C | 1 | 2017 | 5814 | 0.02 | Why? |
| Survival Analysis | 1 | 2020 | 7592 | 0.02 | Why? |
| Symptom Assessment | 1 | 2020 | 4967 | 0.02 | Why? |
| Time Factors | 2 | 2021 | 31397 | 0.02 | Why? |
| Longitudinal Studies | 1 | 2021 | 9893 | 0.02 | Why? |
| Cohort Studies | 2 | 2020 | 36005 | 0.02 | Why? |
| Prospective Studies | 2 | 2021 | 43301 | 0.02 | Why? |
| HEK293 Cells | 1 | 2017 | 8394 | 0.02 | Why? |
| Echocardiography | 1 | 2017 | 3661 | 0.02 | Why? |
| Molecular Docking Simulation | 1 | 2018 | 6902 | 0.01 | Why? |
| Case-Control Studies | 1 | 2021 | 17671 | 0.01 | Why? |
| Host-Pathogen Interactions | 1 | 2021 | 11041 | 0.01 | Why? |
| Viral Load | 1 | 2021 | 15850 | 0.01 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.01 | Why? |
| Age Factors | 1 | 2020 | 21039 | 0.01 | Why? |
| Aged, 80 and over | 2 | 2021 | 88759 | 0.01 | Why? |
| Respiratory Insufficiency | 1 | 2020 | 7301 | 0.01 | Why? |
| Cytokines | 1 | 2021 | 15010 | 0.01 | Why? |
| Hospital Mortality | 1 | 2021 | 22087 | 0.01 | Why? |
| Risk Assessment | 1 | 2020 | 25439 | 0.01 | Why? |
| Inflammation | 1 | 2018 | 13255 | 0.01 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.01 | Why? |
| Risk Factors | 1 | 2021 | 71621 | 0.01 | Why? |
| Intensive Care Units | 1 | 2017 | 29594 | 0.01 | Why? |
| Adolescent | 1 | 2021 | 86841 | 0.01 | Why? |
Zhou's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(176)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(181)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_